Search results for: 'revenue reimbursement'

Healthcare challenges such as workforce shortages, decline in revenue and operating margins, patient payment collection issues, complex claims compliance requirements, and increased patient expectations for seamless experience are compelling healthcare providers to rethink their revenue cycle management (RCM) approach. Providers are realizing the i...

The 5G revolution is upon us. Globally, organizations are embracing the opportunities presented by agile, adaptable, and always-on wireless technologies that help them optimize business processes, deliver new products and services, and improve collaboration among employees and partners. In this dynamic business landscape, businesses are increasingl...

The growth of digital tools and technologies has created new business models for the automotive industry. Today's automotive OEMs are shifting from selling cars to providing mobility solutions by exploring opportunities in several markets, such as electric vehicles, connected and autonomous mobility, and others, to create revenue opportunities. Thi...

The revenue cycle management (RCM) operations space is at a structural inflection, and the convergence of technology, regulations, and dynamic buyer expectations is compelling RCM vendors to act and upgrade their value propositions and strategies to remain competitive. Providers have been under significant financial stress in the past few years. Ho...

20 Mar 2019  |  North America  |  Market Research

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Infographics

×

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

This research service provides an analysis of the procedure volumes and reimbursement trends for heart and lung imaging using magnetic resonance imaging (MRI). Growth opportunities in terms of clinical applications and technologies are provided as well as an overview of unit shipment and revenue forecasts at the global level from 2019 to 2026. Reim...

This Frost & Sullivan study provides an overview of the current state of the global airline revenue management market to understand how airlines are optimizing their revenues, the impact of the COVID-19 pandemic on this market, and the way forward for airlines. The study tracks the latest technologies and market trends that are key variables in det...

This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.

An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing at 3% to 4% every year. While the COVID-19 pandemic in 2020 led to a drop in CT procedures by over 20%, the industry is expected to be completely functional by the end of 2021. Pandemic-based sanitization protocols and patient hesitancy remain restrain...